Monoclonal gammopathy of undetermined significance screening
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
There is no role of screening in patients for monoclonal gammopathy of undetermined significance.
Screening
There is no role of screening in patients for monoclonal gammopathy of undetermined significance.[1]
References
- ↑ Berenson JR, Anderson KC, Audell RA, Boccia RV, Coleman M, Dimopoulos MA, Drake MT, Fonseca R, Harousseau JL, Joshua D, Lonial S, Niesvizky R, Palumbo A, Roodman GD, San-Miguel JF, Singhal S, Weber DM, Zangari M, Wirtschafter E, Yellin O, Kyle RA (July 2010). “Monoclonal gammopathy of undetermined significance: a consensus statement”. Br. J. Haematol. 150 (1): 28–38. doi:10.1111/j.1365-2141.2010.08207.x. PMID 20507313.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH